-+ 0.00%
-+ 0.00%
-+ 0.00%

Hunter Capital RTO 1 Q3 loss after financial items narrows 54% to SEK 59,000

PUBT·10/22/2026 22:01:51
Listen to the news
Hunter Capital RTO 1 Q3 loss after financial items narrows 54% to SEK 59,000
  • Hunter Capital RTO 1’s third-quarter 2026 pretax loss narrowed 54% year-over-year to SEK 59,000.
  • Net sales remained nil for the quarter, while cash totaled SEK 504,000 at September 30.
  • Positive results from ResoTher Pharma’s RTP-026 phase 2a trial fulfilled a key condition for the planned reverse acquisition.
  • The acquisition letter of intent was extended to December 31, 2026; securing financing remains a key requirement for completing the transaction.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hunter Capital RTO 1 AB (publ) published the original content used to generate this news brief via Cision (Ref. ID: 202610221801BITN____UKPR__SV_20261022-BIT-8850-0) on October 22, 2026, and is solely responsible for the information contained therein.